Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 2/20 | 0.48 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | CCR4 | P51679 | 2/20 | 0.48 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.47 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 5/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9113927 | 0.79 | CYP2D6 (0.60) | CCR4KDM4EHSD17B10LMNAHTT | |
| SCHEMBL19386243 | 0.75 | CACNA2D1 (0.52) | FGFR1KDRCACNA2D1CDK1SLC2A1 | |
| SCHEMBL1147601 | 0.73 | KDM4E (0.84) | CDK1KDM4EHSD17B10LMNAHTT | |
| SCHEMBL1147600 | 0.73 | KDM4E (0.82) | CDK1KDM4EHSD17B10LMNAHTT | |
| SCHEMBL1147663 | 0.73 | KDM4E (0.82) | CDK1KDM4EHSD17B10LMNAHTT | |
| SCHEMBL5394802 | 0.72 | TERT (0.56) | FGFR1KDRCACNA2D1KDM4EFLT3 | |
| SCHEMBL5189439 | 0.72 | LMNA (0.64) | CCR4CDK1KDM4EHSD17B10LMNA | |
| SCHEMBL5943593 | 0.72 | TP53 (0.42) | FGFR1KDRCACNA2D1FLT3SLC2A1 | |
| SCHEMBL1147009 | 0.72 | CDK1 (0.81) | CDK1KDM4EHSD17B10LMNAHTT | |
| SCHEMBL10888993 | 0.71 | BCHE (0.53) | CCR4CACNA2D1LMNASLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0617619-B1 | USE OF APP MODULATORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF AMYLOIDOSIS | UNIV ROCKEFELLER (US) | 2003-09-10 | — | — | EP | claimed |
| EP-0617619-B1 | USE OF APP MODULATORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF AMYLOIDOSIS | UNIV ROCKEFELLER (US) | 2003-09-10 | — | — | EP | disclosed |
| EP-0617619-A1 | USE OF APP MODULATORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF AMYLOIDOSIS | THE ROCKEFELLER UNIVERSITY (US) | 1994-10-05 | — | — | EP | disclosed |
| US-5348963-A | Method of screening for modulators of amyloid formation | THE ROCKEFELLER UNIVERSITY (US) | 1994-09-20 | — | — | US | disclosed |
| US-5242932-A | TREATMENT OF AMYLOIDOSIS ASSOCIATED WITH ALZHEIMER DISEASE | THE ROCKEFELLER UNIVERSITY (US) | 1993-09-07 | — | — | US | disclosed |
| WO-1993011762-A1 | USE OF APP MODULATORS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF AMYLOIDOSIS | THE ROCKEFELLER UNIVERSITY (US) | 1993-06-24 | — | — | WO | disclosed |